
Lipocine (LPCN) Earnings Dates & Reports
Lipocine (LPCN) Most Recent Earnings
Report DateMar 13, 2025
Period EndingQ4 2024
Est. EPS-$0.38
Actual EPS$0.33
EarningsBeat
Lipocine (LPCN) Earnings
View the latest Lipocine (LPCN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Lipocine (LPCN)
Order type
Buy in
Order amount
Est. shares
0 shares
Lipocine (LPCN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Lipocine (LPCN) Latest Earnings
The value each LPCN share was expected to gain vs. the value each share gained.
Lipocine (LPCN) reported its most recent earnings on Mar 13, 2025 for Q4 2024, posting earnings per share (EPS) of $0.33. This exceeded analysts' expectations of -$0.38 by 186.84%, marking a Beat.
For comparison, Lipocine reported EPS of -$0.42 in the same quarter last year.
The company is expected to announce its next earnings report on 08/07/2025, with analysts projecting an EPS of -$0.41.
Lipocine (LPCN) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 7, 2025 | -$0.41 | Next earnings call Aug. 7, 2025 | ||
Q1 2025Jul 16, 2025 | – | -$0.35 | — | |
Q4 2024Mar 13, 2025 | -$0.38 | $0.33 | -186.84% | |
Q3 2024Nov 6, 2024 | -$0.48 | -$0.44 | -8.33% | |
Q2 2024Aug 7, 2024 | -$0.78 | -$0.56 | -28.21% | |
Lipocine (LPCN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Lipocine’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 8, 2025 | — | — | — |
Mar 13, 2025 | — | — | — |
Nov 7, 2024 | — | — | — |
Aug 8, 2024 | — | — | — |
Lipocine (LPCN) Earnings FAQs
Lipocine (LPCN) last reported earnings on Mar 13, 2025 for Q4 2024, posting an EPS of $0.33, which Beat the estimate of -$0.38 by 186.84%.
For Q4 2024, Lipocine (LPCN) reported an EPS of $0.33, exceeding analysts' estimate of -$0.38 by 186.84%.
For Q4 2024, Lipocine (LPCN) Beat expectations with an actual EPS of $0.33 vs. an estimated EPS of -$0.38.
Following the last earnings report on Mar 13, 2025, Lipocine (LPCN)'s stock price moved — from — to —.
The next Lipocine (LPCN) earnings call is scheduled for Aug. 7, 2025, where executives will discuss financial results and outlook.